In contrast to conventional T cells, natural killer (NK) 1.1+ T cell receptor (TCR)-α/β+ (NK1+T) cells, NK cells, and intestinal intraepithelial lymphocytes (IELs) bearing CD8-α/α chains constitutively express the interleukin (IL)-2 receptor (R)β/15Rβ chain. Recent studies have indicated that IL-2Rβ/15Rβ chain is required for the development of these lymphocyte subsets, outlining the importance of IL-15. In this study, we investigated the development of these lymphocyte subsets in interferon regulatory factor 1–deficient (IRF-1−/−) mice. Surprisingly, all of these lymphocyte subsets were severely reduced in IRF-1−/− mice. Within CD8-α/α+ intestinal IEL subset, TCR-γ/δ+ cells and TCR-α/β+ cells were equally affected by IRF gene disruption. In contrast to intestinal TCR-γ/δ+ cells, thymic TCR-γ/δ+ cells developed normally in IRF-1−/− mice. Northern blot analysis further revealed that the induction of IL-15 messenger RNA was impaired in IRF-1−/− bone marrow cells, and the recovery of these lymphocyte subsets was observed when IRF-1−/− cells were cultured with IL-15 in vitro. These data indicate that IRF-1 regulates IL-15 gene expression, which may control the development of NK1+T cells, NK cells, and CD8-α/α+ IELs.
Skip Nav Destination
Article navigation
16 March 1998
Brief Definitive Report|
March 16 1998
The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells
Toshiaki Ohteki,
Toshiaki Ohteki
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Hiroki Yoshida,
Hiroki Yoshida
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Toshifumi Matsuyama,
Toshifumi Matsuyama
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Gordon S. Duncan,
Gordon S. Duncan
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Tak W. Mak,
Tak W. Mak
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Pamela S. Ohashi
Pamela S. Ohashi
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Search for other works by this author on:
Toshiaki Ohteki
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Hiroki Yoshida
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Toshifumi Matsuyama
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Gordon S. Duncan
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Tak W. Mak
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Pamela S. Ohashi
From the *Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, Toronto, Ontario, Canada, M5G 2M9; and the ‡Amgen Institute, Toronto, Ontario, Canada, M5G 2C1
Address correspondence to Toshiaki Ohteki, Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, 610 University Ave., Toronto, Ontario, Canada, M5G 2M9. Phone: 416-946-2000; Fax: 416-946-2086; E-mail: [email protected]
Received:
July 07 1997
Revision Received:
December 18 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (6): 967–972.
Article history
Received:
July 07 1997
Revision Received:
December 18 1997
Citation
Toshiaki Ohteki, Hiroki Yoshida, Toshifumi Matsuyama, Gordon S. Duncan, Tak W. Mak, Pamela S. Ohashi; The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells . J Exp Med 16 March 1998; 187 (6): 967–972. doi: https://doi.org/10.1084/jem.187.6.967
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement